Thursday , 7 November 2024
Home Clinical Trial

Clinical Trial

Alnylam Pharmaceuticals
Business

Alnylam Pharma’s Heart Drug Success Surges Stock

Alnylam Pharmaceuticals experienced a significant surge in its stock price, jumping by over 32%, following the successful outcomes of its drug vutrisiran in...

COVID-flu vaccine.
Healthcare

Moderna’s Combo COVID-Flu Vaccine Promising in Trials

Moderna recently announced promising results from its late-stage trial of a combination COVID-19 and flu vaccine. The study revealed that the combination shot...

Amylyx Pharmaceuticals
Healthcare

ALS Drug Relyvrio Withdrawn Due to Ineffectiveness

Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...